Mon, May 12, 9:09 PM (39 days ago)
**DaVita Inc. (DVA) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** $3,223.5 million (up 5% YoY) - **Net Income:** $232.2 million (down 24% YoY) - **Operating Income:** $438.9 million (down 9.3% YoY) - **Earnings per Share (EPS):** $2.05 (down 25% YoY) - **Cash Flow from Operations:** $180 million (up 233% YoY) **Profit Margins:** - **Operating Margin:** 13.6% (down from 15.7% YoY) - **Net Margin:** 7.2% (down from 10% YoY) **Cash Flow:** - **Operating Cash Flow:** $180 million (up 233% YoY) - **Capital Expenditures:** $162.1 million (down 24.7% YoY) - **Free Cash Flow:** -$45 million (up from -$327 million YoY) **Segment Performance:** - **U.S. Dialysis:** Revenue up 2.4% YoY, Operating Income down 9.5% YoY - **Ancillary Services:** Revenue up 21.3% YoY, Operating Income up 75% YoY **Trends & Uncertainties:** - **Treatment Volumes:** Flat QoQ, down 1.6% YoY - **Cybersecurity Incident:** Ongoing, impact on operations and financials uncertain - **Economic Conditions:** Inflation, labor costs, and supply chain challenges persist **Future Operations:** - **Share Repurchases:** $550.2 million spent on repurchases (3.7 million shares) - **Debt:** $9,559.7 million in long-term debt, weighted average interest rate of 5.60% - **Liquidity:** $1,075 million available on revolving credit line **Forward-Looking Statements:** - DaVita expects continued challenges from economic conditions, labor market, and regulatory environment. - The company is focused on cost-saving initiatives, strategic investments, and operational improvements.